SCHEMBL8485694

SCHEMBL8485694

N=C(N)c1ccc(-c2[c]cccc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
WDR5 P61964 1/20 0.57
NQO2 P16083 8/20 0.51
ALDH1A1 P00352 1/20 0.48
TOP1 P11387 1/20 0.48
HPGD P15428 1/20 0.48
CASP1 P29466 1/20 0.48
CASP7 P55210 1/20 0.48
HSD17B10 Q99714 1/20 0.48
PRMT1 Q99873 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
F2 P00734 2/20 0.48
F10 P00742 1/20 0.48
F12 P00748 1/20 0.48
F7 P08709 1/20 0.48
F3 P13726 1/20 0.48
PKM P14618 1/20 0.48
TOP2A P11388 1/20 0.47
TOP2B Q02880 1/20 0.47
BLM P54132 1/20 0.47
PRSS1 P07477 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6605604 0.81 CYP2C19 (0.48) ALDH1A1HPGDHSD17B10TDP1BLM
SCHEMBL10469452 0.76 TSHR (0.48)
SCHEMBL6611172 0.74 MAPT (0.57) ALDH1A1HPGDKMT2ALMNA
SCHEMBL9057820 0.74 WDR5 (0.57) WDR5NQO2F2F10F12
SCHEMBL1411316 0.74 MMP3 (0.48) ALDH1A1HPGDHSD17B10TDP1PKM
SCHEMBL6607460 0.74 CYP3A4 (0.48) ALDH1A1HPGDCASP1CASP7HSD17B10
SCHEMBL8169396 0.74 NQO2 (0.44) WDR5NQO2ALDH1A1TOP1HPGD
SCHEMBL7191695 0.74 NQO2 (0.44) WDR5NQO2ALDH1A1TOP1HPGD
SCHEMBL769959 0.73 ALDH1A1 (0.45) ALDH1A1HSD17B10TDP1
SCHEMBL25097 0.73 ALDH1A1 (0.45) ALDH1A1HSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5925635-A 2-(OXO-1,3-PERHYDRODIAZEPINES OR 3-OXO-2,3,4,5-TETRAHYDRO-1H-2,4-BENZODIAZEPINES; ANTICOAGULANTS; ENZYME INHIBITORS OF SERINE PROTEASE THROMBIN, KALLIKREIN AND PLASMIN; NERVOUS SYSTEM DISORDERS; ANTIINFLAMMATORY AGENTS DUPONT PHARMACEUTICALS COMPANY (US) 1999-07-20 US disclosed